Nu Skin Enterprises Operating Expenses Growth & History (NUS)
Nu Skin Enterprises's operating expenses was $965.6M for fiscal 2025.
View full Nu Skin Enterprises company overviewNu Skin Enterprises annual operating expenses history
| Fiscal year | Period ended | Operating expenses | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $965.6M | −$367.8M | −27.58% |
| 2024 | 2024-12-31 | $1.33B | $24.4M | +1.87% |
| 2023 | 2023-12-31 | $1.31B | −$174.9M | −11.79% |
| 2022 | 2022-12-31 | $1.48B | −$302.6M | −16.94% |
| 2021 | 2021-12-31 | $1.79B | $120.1M | +7.21% |
| 2020 | 2020-12-31 | $1.67B | $94.8M | +6.03% |
| 2019 | 2019-12-31 | $1.57B | −$232.4M | −12.88% |
| 2018 | 2018-12-31 | $1.80B | $301.5M | +20.06% |
| 2017 | 2017-12-31 | $1.50B | $26.3M | +1.78% |
| 2016 | 2016-12-31 | $1.48B | −$36.6M | −2.42% |
| 2015 | 2015-12-31 | $1.51B | −$226.0M | −13.00% |
| 2014 | 2014-12-31 | $1.74B | −$377.9M | −17.85% |
| 2013 | 2013-12-31 | $2.12B | $678.5M | +47.18% |
| 2012 | 2012-12-31 | $1.44B | $275.0M | +23.64% |
| 2011 | 2011-12-31 | $1.16B | $115.5M | +11.02% |
| 2010 | 2010-12-31 | $1.05B | $108.1M | +11.50% |
| 2009 | 2009-12-31 | $939.7M | $46.1M | +5.16% |
| 2008 | 2008-12-31 | $893.6M | — | — |
Nu Skin Enterprises quarterly operating expenses
| Fiscal quarter | Period ended | Operating expenses | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $277.6M | $42.7M | +18.17% |
| Q1 2026 | 2026-03-31 | $210.4M | −$46.4M | −18.07% |
| Q4 2025 | 2025-12-31 | $238.7M | −$93.5M | −28.14% |
| Q3 2025 | 2025-09-30 | $235.1M | −$48.2M | −17.00% |
| Q2 2025 | 2025-06-30 | $235.0M | −$197.8M | −45.70% |
| Q1 2025 | 2025-03-31 | $256.9M | −$28.4M | −9.95% |
| Q4 2024 | 2024-12-31 | $332.2M | −$4.1M | −1.23% |
| Q3 2024 | 2024-09-30 | $283.2M | −$35.4M | −11.11% |
| Q2 2024 | 2024-06-30 | $432.7M | $110.5M | +34.30% |
| Q1 2024 | 2024-03-31 | $285.2M | −$46.6M | −14.03% |
| Q4 2023 | 2023-12-31 | $336.4M | −$10.7M | −3.08% |
| Q3 2023 | 2023-09-30 | $318.6M | −$66.0M | −17.15% |
| Q2 2023 | 2023-06-30 | $322.2M | −$38.8M | −10.74% |
| Q1 2023 | 2023-03-31 | $331.8M | −$59.4M | −15.19% |
| Q4 2022 | 2022-12-31 | $347.1M | −$132.3M | −27.60% |
| Q3 2022 | 2022-09-30 | $384.6M | −$32.3M | −7.74% |
| Q2 2022 | 2022-06-30 | $361.0M | −$85.7M | −19.19% |
| Q1 2022 | 2022-03-31 | $391.3M | −$52.3M | −11.79% |
| Q4 2021 | 2021-12-31 | $479.3M | $14.6M | +3.14% |
| Q3 2021 | 2021-09-30 | $416.9M | −$28.9M | −6.48% |
| Q2 2021 | 2021-06-30 | $446.7M | $46.5M | +11.63% |
| Q1 2021 | 2021-03-31 | $443.5M | $87.9M | +24.71% |
| Q4 2020 | 2020-12-31 | $464.7M | $76.6M | +19.74% |
| Q3 2020 | 2020-09-30 | $445.7M | $65.9M | +17.34% |
| Q2 2020 | 2020-06-30 | $400.2M | $4.9M | +1.24% |
| Q1 2020 | 2020-03-31 | $355.7M | −$52.6M | −12.89% |
| Q4 2019 | 2019-12-31 | $388.1M | −$114.9M | −22.84% |
| Q3 2019 | 2019-09-30 | $379.9M | −$57.3M | −13.11% |
| Q2 2019 | 2019-06-30 | $395.3M | −$57.6M | −12.72% |
| Q1 2019 | 2019-03-31 | $408.3M | −$2.6M | −0.64% |
| Q4 2018 | 2018-12-31 | $503.0M | $84.4M | +20.16% |
| Q3 2018 | 2018-09-30 | $437.2M | $58.7M | +15.50% |
| Q2 2018 | 2018-06-30 | $452.9M | $89.0M | +24.47% |
| Q1 2018 | 2018-03-31 | $410.9M | $69.4M | +20.31% |
| Q4 2017 | 2017-12-31 | $418.6M | $56.6M | +15.63% |
| Q3 2017 | 2017-09-30 | $378.5M | −$17.4M | −4.40% |
| Q2 2017 | 2017-06-30 | $363.8M | −$28.6M | −7.30% |
| Q1 2017 | 2017-03-31 | $341.6M | $15.8M | +4.84% |
| Q4 2016 | 2016-12-31 | $362.0M | −$27.1M | −6.96% |
| Q3 2016 | 2016-09-30 | $395.9M | $19.9M | +5.30% |
| Q2 2016 | 2016-06-30 | $392.5M | $14.3M | +3.79% |
| Q1 2016 | 2016-03-31 | $325.8M | −$43.8M | −11.85% |
| Q4 2015 | 2015-12-31 | $389.1M | −$22.7M | −5.51% |
| Q3 2015 | 2015-09-30 | $376.0M | −$48.6M | −11.44% |
| Q2 2015 | 2015-06-30 | $378.1M | −$61.1M | −13.92% |
| Q1 2015 | 2015-03-31 | $369.6M | −$93.6M | −20.20% |
| Q4 2014 | 2014-12-31 | $411.8M | −$290.7M | −41.38% |
| Q3 2014 | 2014-09-30 | $424.6M | −$175.6M | −29.26% |
| Q2 2014 | 2014-06-30 | $439.3M | −$6.2M | −1.39% |
| Q1 2014 | 2014-03-31 | $463.2M | $94.6M | +25.67% |
| Q4 2013 | 2013-12-31 | $702.5M | $307.3M | +77.76% |
| Q3 2013 | 2013-09-30 | $600.2M | $243.2M | +68.10% |
| Q2 2013 | 2013-06-30 | $445.5M | $45.7M | +11.44% |
| Q1 2013 | 2013-03-31 | $368.6M | $54.0M | +17.17% |
| Q4 2012 | 2012-12-31 | $395.2M | $55.7M | +16.41% |
| Q3 2012 | 2012-09-30 | $357.0M | $66.5M | +22.88% |
| Q2 2012 | 2012-06-30 | $399.7M | $112.5M | +39.18% |
| Q1 2012 | 2012-03-31 | $314.6M | $44.3M | +16.39% |
| Q4 2011 | 2011-12-31 | $339.5M | $68.1M | +25.09% |
| Q3 2011 | 2011-09-30 | $290.6M | $28.7M | +10.95% |
| Q2 2011 | 2011-06-30 | $287.2M | $25.9M | +9.93% |
| Q1 2011 | 2011-03-31 | $270.3M | $17.1M | +6.76% |
| Q4 2010 | 2010-12-31 | $271.4M | — | — |
| Q3 2010 | 2010-09-30 | $261.9M | $30.7M | +13.28% |
| Q2 2010 | 2010-06-30 | $261.3M | $33.8M | +14.85% |
| Q1 2010 | 2010-03-31 | $253.2M | — | — |
| Q3 2009 | 2009-09-30 | $231.2M | — | — |
| Q2 2009 | 2009-06-30 | $227.5M | — | — |
Nu Skin Enterprises operating expenses trends
Over the last five fiscal years, Nu Skin Enterprises's operating expenses decreased from $1.67B to $965.6M, a change of −$700.7M. The latest reported quarter, Q2 2026, shows $277.6M.
What operating expenses mean
Operating expenses are the recurring costs of running a company’s business beyond the direct costs used to calculate gross profit. They commonly include selling, general and administrative expenses, research and development, and other operating costs.
SEC-reported and calculated operating expenses
TickerStat uses operating expenses reported in company SEC filings when available. When a separate total is unavailable, it calculates operating expenses as aligned gross profit minus operating income for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nu Skin Enterprises source filings ↗